Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (111-120 of 627) with videos related to

Pageof 63
Sort By:
American Heart Journal|February 7, 2012
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarctionHarvey D White, Derek P Chew, Harold L Dauerman, et al.
The American Journal of Cardiology|July 28, 2019
A Cluster Analysis of the Japanese Multicenter Outpatient Registry of Patients With Atrial FibrillationTaku Inohara, Jonathan P Piccini, Kenneth W Mahaffey, et al.
American Heart Journal|July 29, 2014
Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndromeAmit N Vora, Michael Chenier, Phillip J Schulte, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Proteomic Insights into the Molecular Correlations Between Coronary Artery Disease and Peripheral Artery Disease in the Project Baseline Health StudyAaliyah Tucker, Maggie Nguyen, Kalyani Kottilil, et al.
The American Journal of Cardiology|June 21, 2006
Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass graftingGlen L Xiong, Wei Jiang, Robert Clare, et al.
European Heart Journal|February 3, 2007
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trialsKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary diseaseMark Y Chan, Kenneth W Mahaffey, Lena J Sun, et al.
Journal of the American Heart Association|July 12, 2014
Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACERHarvey D White, Zhen Huang, Pierluigi Tricoci, et al.
The Lancet. Diabetes & Endocrinology|June 26, 2018
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, et al.
Pageof 63

Showing results (111-120 of 627) with videos related to

Sort By:
Pageof 63
American Heart Journal|February 7, 2012
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarctionHarvey D White, Derek P Chew, Harold L Dauerman, et al.
The American Journal of Cardiology|July 28, 2019
A Cluster Analysis of the Japanese Multicenter Outpatient Registry of Patients With Atrial FibrillationTaku Inohara, Jonathan P Piccini, Kenneth W Mahaffey, et al.
American Heart Journal|July 29, 2014
Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndromeAmit N Vora, Michael Chenier, Phillip J Schulte, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Proteomic Insights into the Molecular Correlations Between Coronary Artery Disease and Peripheral Artery Disease in the Project Baseline Health StudyAaliyah Tucker, Maggie Nguyen, Kalyani Kottilil, et al.
The American Journal of Cardiology|June 21, 2006
Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass graftingGlen L Xiong, Wei Jiang, Robert Clare, et al.
European Heart Journal|February 3, 2007
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trialsKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary diseaseMark Y Chan, Kenneth W Mahaffey, Lena J Sun, et al.
Journal of the American Heart Association|July 12, 2014
Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACERHarvey D White, Zhen Huang, Pierluigi Tricoci, et al.
The Lancet. Diabetes & Endocrinology|June 26, 2018
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, et al.
Pageof 63